While MDSCs and M2 TAMs predominantly express arginase I, NB cells, both from patients and TH-MYCN transgenic mice express predominately arginase II, and this was associated with poor clinical outcome in NB patients [118, 119]. The gene discussed is MYCN; the disease is neuroblastoma.